, cellular proteins can be visualized by genetically encoded fluorescent tags or labels. Ideally, these tags should enable labeled proteins to be studied in intact cells and to preserve their biological functions. Over the past few years, the use of genetically encoded fluorescent proteins such as green fluorescent protein (GFP) or its color variants has become the most popular method to label cellular proteins. The cDNA for GFP can be fused to that of another protein, permitting the expression of a fluorescent fusion protein.
IntroDuctIon

Fluorescent labeling of proteins in intact cells
Studying biomolecules in their native environment in living cells has become a major field of interest in biomedical research. Although lipids or nucleic acids mainly require chemical labeling strategies 1 , cellular proteins can be visualized by genetically encoded fluorescent tags or labels. Ideally, these tags should enable labeled proteins to be studied in intact cells and to preserve their biological functions. Over the past few years, the use of genetically encoded fluorescent proteins such as green fluorescent protein (GFP) or its color variants has become the most popular method to label cellular proteins. The cDNA for GFP can be fused to that of another protein, permitting the expression of a fluorescent fusion protein.
Numerous variants of GFP and other fluorescent proteins with distinct fluorescent properties have been described; they permit various fluorescence techniques for studying the localization and interaction of proteins in intact cells 2 . However, sometimes problems can result from modifying the target protein with these relatively large (~27 kDa) proteins 3 . Genetically encoded alternatives to GFP have been developed, such as the O 6 -alkylguanine-DNAalkyltransferase (AGT, also known as SNAP-Tag). The AGT enzyme can be covalently labeled with O 6 -benzylguanine derivatives that are chemically coupled with various fluorescent compounds; thus, it offers the generation of highly fluorescent labels. Depending on the dyes used and their membrane permeability, this method can be used to label cell surface proteins and intracellular proteins [4] [5] [6] [7] . However, the AGT tags are also of considerable size (~20 kDa). Further fusion protein approaches include dihydrofolate reductase (size ~18 kDa) in combination with fluorescent trimethoprim derivatives 8 ; a modified haloalkane dehalogenase (size ~30 kDa) capable of covalently binding synthetic ligands 9 ; and the acyl carrier protein (size ~10 kDa), which can be labeled with 4′-phosphopantetheine from coenzyme A 10 . Attempts to reduce the still-considerable size of these labels led to the development of alternatives based on smaller genetically encoded labels involving metal chelation strategies 11, 12 . These methods combine an oligohistidine tag with Ni 2 + complexed to fluorescent derivatives of nitrilotriacetate or Zn 2 + complexed to a fluorescein-based chelator HisZiFIT with Zn 2 + . The metal and fluorescent chelator can form a ternary complex with the oligohistidine genetically inserted into the protein of interest. Fluorescence resonance energy transfer (FRET) measurements have been done with purified proteins by combining different fluorescently labeled nitrilotriacetate variants 13 . With sizes of 2-3 kDa, these complexes are much smaller than the GFP variants or the AGT tag, but their low affinity results in a relatively low stability of the complex and, thus, of the labeling 11 . Furthermore, these fluorophores do not cross the plasma membrane; thus, in intact cells, only labeling of proteins at the extracellular face has been achieved 12, 14 . Another technology uses optimized peptide sequences of triple or quadruple repeats of the sequences KIAALKE and EIAALEK, which form coiled-coil interactions based on negative charges in one coil matching positive charges in the second coil 15 . The peptide sequences can be added to a target protein, whereas the second motif is chemically modified with a fluorescent dye. This strategy has been applied to cell surface labeling of target proteins to the labeling procedure and identification of sequences with improved binding properties. In a first step, optimal amino acids for the two central positions were identified, leading to the motif CCPGCC 20 . Subsequently, flanking sequences were optimized, and in particular two 12-amino-acid motifs, FLNCCPGCCMEP and HRWCCPGCCKTF, were introduced 21 . Additional endogenous low-affinity FlAsH-binding sequences have been discovered 22 but have not been of practical utility.
In addition to FlAsH, a set of color variants with different spectral properties and enhanced photostability (e.g., fluorinated variants of FlAsH) has been reported 11, 23, 24 . The most extensively used alternative is the red-shifted analog ReAsH (resorufin arsenical hairpin binder). The two variants FlAsH and ReAsH are commercially available from Invitrogen but can also be synthesized using a recently described procedure 24 . The structure of the motif FLNCCPGCCMEP bound to ReAsH has been solved by NMR 25 , revealing that the peptide sequence forms a hairpin, the details of which explain why Phe1, Pro6 and Gly7 are particularly important for the four cysteines to bind the biarsenical dye with high affinity.
Labeling of proteins with FlAsH and ReAsH can be achieved in intact cells; it is stable and lasts for hours, but it can be quickly reversed if desired. The method has been applied in a large variety of cellular systems and with many different types of proteins. Using common cell lines, labeling with FlAsH and/or ReAsH has been achieved in HeLa, HEK293, COS-7 and CHO cells [26] [27] [28] [29] [30] as well as in primary cortical neurons 31 . It has also been used successfully in Gram-negative bacteria such as Shigella flexneri 32 and Escherichia coli strains 33 . The small size (< 0.7 kDa) of FlAsH and ReAsH has also permitted the study of fluorescently labeled viral proteins, whereas the larger GFP tag would hinder virus packing 34, 35 . Successful labeling has even been reported in vivo in Drosophila eyes 36 . In addition to straightforward labeling experiments, FlAsH and ReAsH have also been used for more complex investigations. For example, sequential pulse labeling of proteins with FlAsH and ReAsH has been developed for selective labeling of newly synthesized proteins 18, 31 . Chromophore-assisted light inactivation of ReAsH-or FlAsH-labeled proteins has permitted rapid photochemical inactivation of specific proteins in intact cells 37, 38 and also in vivo in Drosophila eyes 36 . Furthermore, FlAsH has been used in combination with a second fluorophore in FRET studies. Fluorescent proteins, such as the cyan fluorescent protein (CFP) as well as ReAsH, have been used as FRET partners. These FRET studies have allowed the investigation of conformational changes in individual proteins and of protein-protein associations 17, 28, 29, [39] [40] [41] [42] . Alternatively, conformational changes of proteins as well as proteinprotein interactions can also be studied by measuring the fluorescence intensity of FlAsH binding to split versions of the binding sequence 43 . This approach is based on the fact that fluorescence intensity increases on binding to its target sequence 17 ; because of conformational changes, the split sequences approach closely and allow FlAsH to bind to the sequence 43 . Several low-and high-affinity FlAsH-binding sequences have been recently described 21, 22 . The group of Squier and Meyer presented a variant tetracysteine motif, CCKACC, with different binding rates and affinities for FlAsH and ReAsH compared with the CCPGCC motif. This approach allowed sequential labeling, but it has so far been used only with purified proteins 44 . A very recent addition to these protocols has been the development of a selective labeling strategy that permits the orthogonal labeling of two different tetracysteine motifs with FlAsH and ReAsH 45 . Such selective labeling allows the simultaneous study in intact cells of two proteins of interest, each labeled with its own color, as well as the investigation of their interactions by colocalization and FRET experiments.
Comparison of FlAsH and GFP labeling
FlAsH labeling aims for a 1:1 stoichiometry of FlAsH:tetracysteine motifs with low background. Using the protocol described here, such complete labeling can be achieved within a short time. Background staining is then reduced by a washing procedure; this washing procedure can also reduce specific labeling if too-high antidote concentrations are used. This potential loss is minimized if the newer 12-residue motifs are used. Specificity of labeling can be ascertained by several controls. The simplest strategy is to compare cells expressing the tetracysteine-harboring protein with nontransfected control cells or-even better-with cells expressing the same protein but lacking this motif 28 . A second strategy-used here for illustration purposes-involves fusion of tetracysteine-harboring proteins with a GFP variant. Although this approach negates the advantages of the small FlAsH label, it permits exact colabeling controls. Otherwise, this approach should only be used when a second label is required, e.g., for FRET experiments or to excite FlAsH by means of a second fluorophore. It has been reported that direct excitation of ReAsH had a 90% reduced contrast compared to GFP alone 21 ; however, in combination with GFP and excitation by FRET, the contrast was only decreased by 50% (ref. 21) . Generally, the contrast should be better when using the high-affinity 12-amino-acid motif compared with the 6-amino-acid motif, as the wash buffer includes higher concentrations of the antidote 21, 45 . Multiple repeats of the tetracysteine motif resulted in a modest increase in brightness 46 , but the labeling did not achieve the 1:1 stoichiometry seen for single motifs. When multiple repeats of the motif were added to β-tubulin, protein function was less conserved; with two repeats, the protein still functioned, but three repeats ablated the protein function 47 . Concerns about the cytotoxic effects of reagents, in particular of the washing procedure, have been raised 19, 48 and should therefore be addressed. Although damage to individual cells can occasionally be observed after the labeling procedure, our experience with the technique does not support the notion of a general cytotoxicity. For example, cell signaling pathways remain functional after labeling with FlAsH. This includes the activation of G protein-coupled receptors 28, 29, 42 , as well as the activation of PKC pathways, as a cytosolic PKC-FRET probe was phosphorylated normally after FlAsH labeling 41 . GPCRs labeled with FlAsH or ReAsH have been shown to continue to internalize after agonist stimulation 30, 45 , indicating that the endocytotic machinery remains functional, and the receptor recruits β-arrestin to the plasma membrane 45 . Similarly, this labeling approach allows the transport of newly synthesized proteins in dendrites 31 , indicating that targeting of proteins remains functional. Ion channels (L-type calcium channels 37, 49 50 . Taken together, these data suggest that many cellular functions remain normal after labeling with biarsenical dyes. However, notwithstanding this general point, it seems useful to ascertain the functionality of the specific biological process after this labeling procedure.
Experimental design
This method seems to be widely applicable to different biological systems and proteins. However, a detailed protocol on how to use and optimize it has been lacking. Therefore, the following sections describe these basic procedures in a step-by-step manner and emphasize potential problems and their solutions.
The full procedure involves modifying a protein of interest by insertion of a tetracysteine site, followed by monitoring of its expression in cells (or intact organisms) and, finally, labeling the protein with FlAsH or ReAsH. The first step generally requires some knowledge of the protein of interest and the identification of sites where a tetracysteine motif may be placed without disturbing protein function. In general, we prefer to replace an endogenous stretch of amino acids with the tetracysteine motif. To genetically encode the core tetracysteine motif, CysCysProGlyCysCys, we generally use the codon sequence 5′-TGTTGCCCGGGCTGCTGT-3′. This codon sequence contains a SmaI/XmaI restriction site (underlined sequence) and thus allows easy screening for positive clones. Once the tetracysteine-tagged protein has been cloned and its expression, distribution and function have been tested in the cell line of interest, biarsenical dyes are used to fluorescently label the protein and thus visualize it. In general, one should try to minimize excess light exposure of the FlAsH reagent. The preparation for labeling can be done under normal room light, but direct sunlight should be avoided. The 1-h incubation time and later storage of cells should be done in a cell incubator, thereby automatically occurring in the dark. The entire labeling procedure must be done in a fume hood. EDT and the less-odorous BAL (2,3-dimercaptopropanol or British anti-Lewisite) are both hazardous and smell unpleasant. However, these dithiol antidotes are important components of the tetracysteine-biarsenical method and need to be used. BAL is somewhat less noxious but hinders labeling because its complexes with biarsenical dyes are tighter and less membrane permeant; thus, it should not be used for the labeling step but rather should be limited to the washing steps.
The following standard protocol has been established and tried with several different proteins, including some with very low levels of expression. We have found the same protocol useful for all proteins that we have labeled and thus believe that it is generally applicable. To demonstrate its feasibility, most of the images we show here as examples (see PROCEDURE and ANTICIPATED RESULTS) relate to G protein-coupled receptors. In particular, we focus on the A 2A -adenosine receptors, which are examples of cell surface proteins and are expressed at densities below 1 pmol mg -1 of cellular protein, as well as their regulatory proteins, the β-arrestins, which are examples of cytosolic proteins and are expressed at similarly low levels. Thus, for proteins expressed at higher levels, the results, particularly the signal-to-noise ratios, should exceed those presented here. Dishes for cell culture REAGENT SETUP Labeling buffer Standard commercial HBSS ('complete' , no phenol red; see below) can be used for the labeling reaction. Instead of HBSS, one may also use the imaging buffer (see below) for labeling, and presumably many other buffers will also work. It is important, however, that no plasma or serum be added to the buffer because albumin binds the biarsenical dyes. Buffers can be prepared in advance in larger quantities and stored at 4 °C for several weeks. To improve storage time of HBSS, glucose should be added freshly before use. Hank's balanced salt solution To make HBSS (pH 7.4), combine 137 mM NaCl, 5.4 mM KCl, 0.3 mM Na 2 HPO 4 , 0.4 mM KH 2 PO 4 , 4.2 mM NaHCO 3 , 1.3 mM CaCl 2 , 0.5 mM MgCl 2 , 0.6 mM MgSO 4 and 5.6 mM glucose.
MaterIals
REAGENTS
XmaI (NEB, 5,000 U, cat. no. R0180S) SmaI (NEB, 2,000 U, cat. no. R0141L) TC-FlAsH (Invitrogen, labeling kit, cat. no. T34561)  crItIcal Invitrogen is the only commercial supplier, but we have successfully used self-synthesized reagents (our FlAsH-EDT 2 stock is 1 mM in DMSO; stock solutions are stored at − 20 °C) TC-ReAsH (Invitrogen, labeling kit, cat. no. T34562)  crItIcal Invitrogen is the only commercial supplier, but we have successfully used self-synthesized reagents. EDT (1,2-ethanedithiol, grade for synthesis >99%; Merck, cat. no. 8.00795.0100) ! cautIon The compound has a bad odor. Handle in a well-ventilated fume hood. BAL (2,3-dimercapto-1-propanol, grade purum p.a. 97%; FLUKA, cat. no. 38520) ! cautIon The compound has a bad odor. Handle in a wellventilated fume hood. DMSO (dimethylsulfoxide, cell culture grade; AppliChem, cat. no. A3672.0250) ! cautIon DMSO is irritating to eyes, respiratory system and skin; wear suitable gloves and eye and skin protection. Ethanol (absolute, p.a. >99.8%; Sigma-Aldrich, cat. no. 33205) Sodium chloride (NaCl) Potassium chloride (KCl) Sodium phosphate, dibasic (Na 2 HPO 4 ) Potassium phosphate, monobasic (KH 2 PO 4 ) Sodium bicarbonate (NaHCO 3 ) Calcium chloride (CaCl 2 ) Magnesium chloride (MgCl 2 ) Magnesium sulfate (MgSO 4 ) Glucose HEPES Reagents for cell culture (these will vary according to desired cells and culture conditions) Imaging buffer To make imaging buffer (pH 7.3), combine 140 mM NaCl, 5.4 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 and 10 mM HEPES. Cell culture Cells may be cultured under any conditions before labeling, depending on their specific needs. For example, HEK cells are cultured in DMEM (4.5 g per liter of glucose) supplemented with 10% (vol/vol) FCS, 100,000 U per liter of penicillin and 100 mg per liter of streptomycin at 37 °C and 7% CO 2 . Cells and protein expression Cells used for labeling need to express the protein of interest carrying the tetracysteine motif. This motif can be either the 6-amino-acid motif CCPGCC 20 or, preferably, one of the more recently described 12-amino-acid motifs (such as FLNCCPGCCMEP21), which display higher affinity for FlAsH (see INTRODUCTION). The choice will depend on the insertion site and the ability of the modified protein to maintain its function. In general, we tend to replace the native stretch with the binding sequence rather than insert the sequence; we hope that this will affect the overall structure of the modified protein to a lesser extent.
Ideally, stably transfected cell clones should be used if correct targeting of the expressed protein is a problem (e.g., targeting to the cell surface). However, transient transfections have the advantage of speed, together with usually higher expression levels, and they avoid possible clonal artifacts. Routinely, we use HEK293 cells transiently transfected with any standard transfection method using either calcium phosphate or transfection reagents such as Effectene (Qiagen), Lipofectamine (Invitrogen) or GeneJuice (Novagen). Other cell lines such as HeLa, PC12 or CHO have also been used, as have primary neurons. Generally, cells are used 48 h after transfection (transfections are done at 40-50% confluence). Cells should be plated on polylysine-coated coverslips (24 mm in diameter) or on similar devices (such as MaTek dishes); they are handled on these coverslips throughout the procedure. We routinely grow the cells in six-well plates, with each well containing a 24-mm-diameter coverslip. proceDure preparation of dyes for labeling 1| In a silanized polypropylene tube, prepare a 25 mM EDT solution in DMSO by mixing 2.1 µl of EDT with 1 ml of DMSO.  crItIcal step Stock solutions of dithiols should be prepared freshly before use, as they are prone to air oxidation. EDT has only limited solubility in aqueous solutions; hence, DMSO or absolute ethanol should be used for preparing concentrated solutions (above millimolar concentrations).
2|
In a separate silanized polypropylene tube, add 1 µl of freshly prepared 25 mM EDT and 1 µl of FlAsH stock for each sample to be labeled.  crItIcal step For a final concentration of FlAsH, we use a 1 mM FlAsH-EDT 2 stock in DMSO, whereas the stock currently provided by Invitrogen is 2 mM FlAsH-EDT 2 in DMSO/H 2 O (TC-FlAsH, cat. no. T34561). This is important to note, as one may need to recalculate the appropriate volumes. The described protocol is given for a final 2-ml incubation volume. Our final working concentration for the FlAsH labeling is 500 nM in a six-well tissue culture plate. In our hands, this has proven to be a good starting concentration for labeling of new constructs modified with the core sequence CCPGCC.
3|
Incubate at room temperature (20-25 °C) for 5-10 min. This step ensures that all FlAsH is in the FlAsH-EDT 2 form. While incubating the EDT/FlAsH mix, prepare the cells as described in Steps 4 and 5 below. labeling 4| Wash the tissue culture dish twice with 2 ml of 1× HBSS/glucose.  crItIcal step The complete removal of medium is necessary, as the remaining serum proteins may interfere unpredictably with the labeling reaction. Biarsenical dyes, like many synthetic dyes, bind reversibly to hydrophobic pockets on proteins such as BSA and may become fluorescent 51 . To decrease such competitive binding, which hinders the desired labeling, we generally wash off the cell growth medium before labeling and perform the labeling step in HBSS/glucose, PBS or the specific cell growth medium without serum. The labeling buffer should always contain Ca 2 + and Mg 2 + to prevent cells from detaching. We previously introduced Patent Blue and Disperse Blue to quench FlAsH bound to both extracellular and intracellular hydrophobic sites, respectively 51 . However, they only give a modest increase in contrast (twofold) and do not seem to be useful for ReAsH. We routinely use phenol red-free buffer to avoid any unnecessary dye for fluorescence imaging.
5| Add 1 ml of HBSS/glucose solution to the dish. If several samples need to be treated, carry out Steps 4 and 5 sequentially on smaller batches of samples to prevent the cells from being left dry for long periods of time.
6|
For each sample to be labeled, add 1 ml of HBSS/glucose into a Falcon tube.
7| Take a small aliquot (50-100 µl per sample) from this HBSS/glucose and add it to the EDT/FlAsH solution prepared in Step 2.
8| Mix well by pipetting up and down and let the EDT/FlAsH/HBSS solution incubate for 5 min. This step ensures that the FlAsH/EDT in DMSO will mix homogeneously in a small volume and that it will later mix without problems in the larger volume of HBSS/glucose.
9| Add the solution from
Step 8 to the Falcon tube containing the remaining HBSS/glucose from Step 6 and mix thoroughly by repeatedly inverting the Falcon tube to ensure a homogeneous solution.
10| Add 1 ml of this solution to each dish. Gently swirl the labeling solution to ensure initial mixing and incubate the tissue culture dish for 1 h at 37 °C (with a humidified atmosphere and CO 2 as appropriate for the buffer and cell type used). Thus, the concentrations during labeling are 500 nM FlAsH/EDT 2 , 12.5 µM EDT and 0.1% (vol/vol) DMSO.  crItIcal step The incubation time that is necessary to reach full labeling of all sites with FlAsH may vary. In Figure 1 , binding FlAsH to CFP-labeled A 2A -adenosine receptors was monitored by quenching of the CFP fluorescence 28 . With this approach it can be seen that, in living HEK293 cells, the binding motif CCPGCC is saturated using 500 nM FlAsH in less than 1 h. No further decrease in CFP fluorescence was observed after full saturation, as seen by reaching a plateau after 35-45 min. Therefore, an incubation time of 1 h includes a safety margin to ensure full occupancy of all available sites. We recommend using 10-15 µM EDT during the labeling step; higher concentrations increase specificity but slow down reaction rates. EDT is used during the labeling step, as BAL appears to decrease the membrane permeability of the biarsenical dyes, probably because the arsenic-BAL complex is more stable, rapidly displaces the EDT bound to each arsenic group and introduces two polar alcohol groups.
Reaction with biarsenical dyes requires that the cysteine thiols of the tetracysteine tag be reduced. Cellular redox mechanisms maintain cytoplasmic tetracysteine in this form, but oxidizing cellular compartments such as the Golgi apparatus and extracellular space requires acute reduction with stronger reducing agents such as phosphines 50 .
removal of excess and nonspecifically bound dye 11| Prepare washing solution by mixing 42 µl of EDT with 1 ml DMSO (500 mM EDT in DMSO).  crItIcal step Stock solutions of dithiols should be prepared freshly before use as they are prone to air oxidation. EDT has only limited solubility in aqueous solutions; hence, DMSO or ethanol should be used for making concentrated solutions (above millimolar concentrations).
12| Add 25 µl of the 500 mM EDT in DMSO to 50 ml of HBSS/glucose solution, resulting in an HBSS/glucose solution containing 250 µM EDT (washing solution, room temperature).
13|
Aspirate the supernatant from the cells and add 2-3 ml of 250 µM EDT washing solution. Incubate the cells for 10 min at 37 °C (humidified atmosphere and CO 2 as necessary for the buffer and cell type used).  crItIcal step The effect of this washing step is illustrated in Figure 2 with transiently transfected HEK cells. The concentration of EDT used to compete for nonspecific binding is crucial. If the concentration used is too low, the background fluorescence may remain unnecessarily high, whereas using too high concentrations will diminish the specific binding. We currently use EDT for standard applications, but we have also used the less-odorous BAL. Figure 3 illustrates the BAL-resistance of the newly described motifs (FLNCCPGCCMEP or HRWCCPGCCKTF) in comparison with the CCPGCC motif. BAL has an approximately threefold higher potency in displacing FlAsH from its specific binding motif than does EDT (see Fig. 4 ). Figure 3 shows that, for the motif CCPGCC 21 , specific binding starts to be affected when washing is done with BAL concentrations higher than 100 µM. At 250 µM BAL, up to 30% of the specifically bound FlAsH is displaced. The Invitrogen kit currently provides a new wash buffer using 250 µM BAL instead of 250 µM EDT to reduce the odor. However, for the protein shown here, this concentration appears to be too high. Figure 3 also shows that the new motifs have a much better resistance to displacement of specific binding by BAL. Therefore, higher BAL concentrations can be used with the new motifs to reduce nonspecific binding while leaving the specific binding unaffected.
14|
Aspirate the supernatant and wash the cells with 2-3 ml of HBSS/glucose solution without EDT.
15| Repeat
Step 14 one or two additional times to reduce remnants (and odor) of EDT. Cells are now ready to be imaged (see Box 1 for details). In the case of larger sample numbers, we add cell culture medium used to culture the particular cell line instead of buffer and store cells at 37 °C (humidified atmosphere and CO 2 as appropriate for the medium and cell type used) until use. Thereafter, before imaging, wash cells with the imaging buffer as described in Step 4 (to remove phenol red); all measurements should be done in this buffer. We have studied cells up to 8 h after labeling and have not observed changes in cell morphology during this time.
• tIMInG The entire labeling procedure (Steps 1-15) using FlAsH-EDT 2 as described takes 2-3 h, depending on the number of samples to be processed as well as on the experience of the researchers in conducting the labeling. There is no pause point within the procedure, but the 1-h incubation time in
Step 10 can be used to prepare the microscopes for later sample imaging. The construct termed CCPGCC is identical to the one used in Figure 2 ; the CCPGCC motif in this construct is flanked by the normal A 2A sequence environment, finally reading ESQCCPGCCARS. In the construct termed FLNCCPGCCMEP, the binding motif was introduced N-terminally to the CFP, replacing the corresponding amino acids of the A 2A receptor. Cells were labeled with FlAsH, and membranes from these labeled cells were prepared as described 42 . Fluorescence spectra of homogenized membranes were measured in a fluorescence spectrophotometer. Thereafter, BAL was added at increasing concentrations, and for each concentration, fluorescence spectra were recorded after 10 min of incubation time. Spectra were recorded using 436-nm excitation (excitation bandwidth 5 nm) and emission was recorded from 460 to 700 nm (bandwidth 5 nm, scan speed 200 nm min − 1 ). The ratios of the fluorescence emission peaks at 480 nm (CFP) and 528 nm (FlAsH) were calculated and plotted against increasing BAL concentrations to determine the fraction of FlAsH bound (as percentage of the prewash value) 45 . Squares represent the basic CCPGCC motif, whereas circles represent data for the motif FLNCCPGCCMEP. Note that the optimized motifs exhibit a much greater (10-to 30-fold) resistance to displacement by BAL. The figure is modified with permission from Zürn et al. 45 . were incubated with FlAsH as described in the above protocol, and then membranes from these cells were prepared. Fluorescence spectra of homogenized membranes were measured in a fluorescence spectrophotometer as in Figure 3 . Thereafter, BAL or EDT was added at increasing concentrations; at each concentration, fluorescence spectra were recorded after 10 min of incubation. BAL had an approximately threefold higher potency than EDT in displacing FlAsH from its specific binding motif.
? trouBlesHootInG This procedure does not allow the assessment of the success of labeling at any intermediate step; however, table 1 provides advice for troubleshooting should no labeling or nonspecific labeling be observed at the end of the PROCEDURE. In general, we strongly recommend the use of control constructs that allow the potential source of the problem to be narrowed down. Cells expressing recombinant, nontetracysteine-tagged host protein or, more simply, nontransfected cells are good negative controls. Careful choice and use of negative controls will help determine the baseline and potential signal/noise problems related to the specific cell type. Similarly, positive controls are valuable tools in the fine tuning of labeling with biarsenical compounds. We have found that adding other molecular tags to the tetracysteine fusion is a simple, efficient way to generate internal positive controls (see use of CFP in Fig. 2 ).
Box 1 | IMAGING CELLS confocal microscopy
Direct excitation of FlAsH can be done using the 514-nm wavelength of an argon laser with the standard settings for visualizing yellow fluorescent protein.
Fluorescence emission of FlAsH can be recorded using the manufacturer's settings for yellow fluorescent protein.
Laser intensity should be kept low to minimize photobleaching of the fluorophore. Cells can be observed with objectives of high magnification (×63 or ×100) for analysis of single cells, or with low magnification (×10 or ×20 objectives) for analysis of cell ensembles.
Fret recordings
FRET recordings are made with a fluorescence microscope. Use objectives with high magnification (×63 or ×100) for analysis of single cells, or use objectives with low magnification (×10 or ×20) for analysis of cell ensembles.
FRET recordings can be done using either photodiodes or CCD cameras to record the emissions of the donor and the acceptor. Cells labeled as described (Steps 1-15) are mounted on an Attofluor holder and placed on an inverted microscope (e.g., Zeiss Axiovert 200) equipped with a dual-emission photometric system (e.g., Till Photonics) to record separately the two emission wavelengths.
Excitation for standard recording is done at the optimum wavelength for the donor. Shutters or a tunable light source (e.g., Polychrome IV, Till Photonics) are essential. Switch on the excitation light only when observations are being made in order to minimize photobleaching and phototoxicity, as FlAsH bleaches with similar kinetics as fluorescein.
Illumination and recording times of 5-40 ms for each data point are generally sufficient. Emission levels of donor and acceptor wavelengths are recorded simultaneously using a beam splitter that divides the emissions of the donor and acceptor fluorophores (e.g., 480 nm for CFP and 535 nm for FlAsH).
FRET can then be monitored as the emission ratio of FlAsH over CFP 14 . Examples for filters and beam splitters in the emission path for such experiments are 535 ± 15 nm (FlAsH) and 480 ± 20 nm (CFP), using a dichroic long-pass beam splitter DCLP 505 nm.
Excitation can be done at 436 ± 10 nm (e.g., for CFP) with a dichroic long-pass beam splitter DCLP 460 nm. The respective spillover between channels (i.e., direct excitation of FlAsH by 436-nm light and emission of CFP into the 535-nm channel) needs to be corrected by the respective measurements of controls labeled with CFP alone or with FlAsH alone before a corrected F* 535 /F* 480 ratio (F* denotes corrected fluorescence) can be calculated.
The factors for such corrections need to be frequently determined, as they vary not only with the age of light sources but also with the type of instrumentation and other specific influences.
To monitor acute changes in FRET with such a system, cells should be continuously superfused with buffer, and compounds can then be applied using a computer-assisted solenoid valve-controlled rapid superfusion device (e.g., ALA-VM8, ALA Scientific Instruments; solution exchange in 5-10 ms).
Signals can be detected by photodiodes or with CCD cameras. There are different motifs that can be used for labeling of a host protein (see Fig. 3 and references); choose motifs to minimize perturbation of host protein and background staining CCPGCC: shorter length, less resistant to EDT or BAL treatment, potentially more background staining left. We recommend this motif if an insertion into the host protein is desired. If N-or C-terminal tagging is possible, longer motifs are recommended FLNCCPGCCMEP: longer sequence, more resistant to EDT or BAL treatment, most likely less background staining. When this sequence is inserted, it may eventually be more perturbing to the host protein than the CCPGCC motif, but this needs to be verified (continued) 
problem possible reason solution
Cells are not transfected
If cells are difficult to transfect or if a protein of interest does not express well, it may be necessary to identify transfected cells with a second label. This label may be in a separate protein or fused to the protein of interest (e.g., CFP, see above). This will help to verify that transfected cells are investigated and makes it possible to judge whether the labeling procedure works for the desired protein of interest Low-expressing protein Obviously, better labeling is obtained with abundantly expressed proteins. We demonstrate in this protocol that it can be used to label proteins with expression levels below 1 pmol mg -1 of protein, both for membrane proteins and cytosolic proteins. Lowexpressing proteins may not produce a good signal-to-noise ratio. We recommend using 12-amino-acid tetracysteine motifs to minimize background staining by stronger washing Yellow fluorescence observed but no specific labeling (see Fig. 2 )
Incomplete washing
Nonspecifically bound FlAsH remains in the cells that will mask the signal. We recommend repetition of Steps 13 and 14 for a second round of washing
Inappropriate incubation time
The incubation time is critical to allow complete labeling of the protein.
As can be seen in Figure 1 , the target protein showed exponential saturation kinetics for labeling. The time periods given here assure virtually complete labeling with both FlAsH and ReAsH. Accurate determination of labeling time courses is best achieved as described in Figure 1 . Further increases in incubation time while using high FlAsH concentrations most likely increases only nonspecific binding. A decrease in incubation time may result in unoccupied binding motifs. We are currently testing whether longer labeling time periods with lower concentrations of FlAsH (50-100 nM) may produce higher signal-to-noise ratios Inappropriate concentration of the wash solutions
The correct wash procedure is a major issue for this technique. Figure 2 illustrates results with and without washing. Figure 3 illustrates that the CCPGCC motif can be washed with up to 100 µM BAL without displacing specifically bound FlAsH, whereas the FLNCCPGCCMEP resists up to 1 mM BAL, a concentration that would already displace 75% of the specific binding from the 6-amino-acid motif Inappropriate use of EDT or BAL as antidotes for washing
Because BAL is less odorous than EDT, one can use BAL instead for washing. ! cautIon the two reagents are not equal with respect to their strength in displacing FlAsH from the specific binding motif: BAL is apparently threefold more effective in displacing FlAsH (Fig. 4) The recent change in the protocol supplied by Invitrogen might be of concern. Until recently, the kit was sold with 250 µM EDT for washing. Now the kit is supplied with a washing solution containing 250 µM BAL instead. This should be kept in mind, if one plans to use the 6-amino-acid CCPGCC tag. Figure 4 illustrates that with 250 µM BAL the bound fraction is displaced in part and thus the specific signal is reduced by 25%. This is not the case for the improved 12-amino-acid tag
Tetracysteine is localized in an oxidizing environment such as the Golgi apparatus or on the extracellular side of the plasma membrane Successful labeling requires that the cysteine thiols of the tetracysteine tag be reduced. In oxidizing cellular compartments, acute reduction with stronger reducing agents such as phosphines may be required. We have used membrane-permeant phosphines such as tributylphosphine (TBP) or triethylphosphine (TEP) to label targets in oxidizing environments inside organelles in living cells. Both TEP and TBP are prepared fresh in ethanol (1 M solutions) and diluted 1:1,000 directly into the labeling mixture with the biarsenical in Step 8. Phosphines react with DMSO and cannot be stored for any length of time in that solvent For tetracysteines facing the extracellular milieu, the best conditions so far (S. Terrillon, unpublished results) for live mammalian cells have been: reduction of extracellular disulfides with the membrane-impermeant reducing agents MES (5 mM) and TCE (0.5 mM) for 30 min at 37 °C; labeling with 2.5 µM ReAsH or sulfo-FlAsH 20 in the presence of the reducing agents used in the previous step and 5 µM DMPS (a membrane-impermeant analog of EDT) for 10 min at 37 °C; and removal of nonspecific binding with 100 µM DMPS for 10 min at 37 °C. DMPS prevents ReAsH from crossing the plasma membrane and would probably do the same with FlAsH as well, which would avoid the requirement for sulfo-FlAsH, which is not commercially available (see also Fig. 7) antIcIpateD results If the tetracysteine tag is intended to be used for labeling and visualization of the protein of interest, cDNA construction may only take a few days, especially if the tag can be placed in a region known to be tolerant of concatenation or substitution. When the placement of the motif must be varied to maximize FRET signals or minimize perturbation of physiological function, a thorough optimization may be required and this process can take significantly longer. For general strategies on FRET-probe design, we refer to a recent publication 52 . As the probe design is a very individual process and depends on biological application, it is impossible to give an estimated timeline for probe generation. As already mentioned, we find it useful to encode the desired CCPGCC motif with the nucleotide sequence 5′-TGTTGCCCGGGCTGCTGT-3′.This results in an additional cut by the restriction enzymes XmaI or SmaI and makes it easy to distinguish modified versus nonmodified DNA sequences by the appearance of distinct patterns in gel electrophoresis.
Once the desired construct has been generated and expressed in cells, the labeling protocol described here can be applied. The results shown here were obtained with proteins expressed at low levels, such as cell surface receptors (Fig. 2) or cytosolic β-arrestins (Fig. 5) ; both were expressed at levels below 1 pmol mg -1 of cellular protein. Better results can be expected with more abundantly expressed proteins.
In Figure 2 , we expressed a previously published cell surface receptor construct 28 and labeled the cells until Step 10. Next, we placed the cells on a confocal microscope and continued the procedure on the microscope. The pictures in the top row show the results of the labeling protocol before the washing steps (Steps 11-13) , whereas the bottom row shows the same cells when EDT washing solution was added to the cells while they remained on the microscope (i.e., this represents a very incomplete washing procedure). With this experiment, we can simulate what we refer to as insufficient washing, and this likely reflects a situation that many researchers have observed when they started with this technique. From the top row of images, one might conclude that no specific labeling had been achieved. However, this is clearly not the case, as demonstrated by the images in the bottom row. It can be seen that the construct had been specifically labeled, but when no washing was performed, the nonspecific background was too high to visualize the specific label. The nontransfected cells in the panels, which can be easily distinguished here by the CFP fused to the protein of interest, serve well as internal controls for background staining and they help in judging the quality of the washing procedure. Obviously, such additional CFP-fusion should only be used as a control, given the size advantage of the small FlAsH label (unless a second label is wanted).
As different binding motifs can be used 20, 21 , it is important to analyze their individual affinity carefully. Figure 3 demonstrates the difference of motifs FLNCCPGCCMEP and CCPGCC in the stability of their FlAsH binding with respect to removal by BAL 45 . This different stability of bound FlAsH has consequences for the washing procedure of differently tagged proteins. If a protein tagged with the sequence FLNCCPGCCMEP is washed with 250 µM BAL, background labeling will be reduced, but specific labeling will not be reduced until BAL concentrations exceed 1 mM. However, if the same construct is made using the short CCPGCC motif, washing with 250 µM BAL will already reduce specific labeling by 25-30% and 1 mM BAL will reduce specific labeling to almost background. This needs to be kept in mind when working with these tags. A special case is demonstrated in Figure 4 . The initial antidote for washing was EDT and this can be exchanged for BAL to reduce the unpleasant odor during the labeling process. However, Figure 4 demonstrates that EDT and BAL are not equal with respect to displacing FlAsH from its binding motif. It can be seen that BAL is approximately threefold more potent in displacing FlAsH compared with EDT (see also Step 12 and TROUBLESHOOTING).
The same protocol can be applied to cytosolic proteins 41, 45 . A β-arrestin-2-CCPGCC construct and the human PTH (parathyroid hormone) receptor 45 were transiently expressed in HEK293 cells. At 48 h after transfection, the cells were labeled according to this protocol. Top row: cells labeled with FlAsH were excited at 514 nm and emission was measured from 530-600 nm (i.e., FlAsH fluorescence). The right column represents transmission images of the cells. The white scale bar = 10 µm. Bottom: the same cells were monitored 9 min after addition of 1 µM PTH (1-34). After PTH (1-34) addition, a clear translocation of FlAsH-labeled β-arrestin-2-CCPGCC to the membrane is visible, indicating that cytosolic proteins such as β-arrestin-2 can be specifically labeled and maintain their function 45 . The figure is modified with permission from Zürn et al. 45 .
of the cytosolic protein β-arrestin-2 according to this protocol, again expressed at a low level of ~1 pmol mg -1 of cellular protein; better results can be expected for more abundantly expressed cytosolic proteins. Nontransfected cells indicate background staining. Functionality of the labeled β-arrestin-2 is demonstrated by the fact that it can be recruited to the cell surface by stimulation of a cotransfected receptor 45 . FlAsH labeling can be done alone to visualize proteins, or with a second label for FRET studies. The second label may be a fluorescent protein (such as CFP, together with FlAsH 28, 29, 41, 42, 53 ) or a small second label such as ReAsH 38, 45, 54 . Details on how to perform FRET measurements are described in Box 1. Figure 6 shows a FRET recording as described in Box 1 using FlAsH and CFP as labels to monitor stimulusdependent conformational changes in the α 2A -adrenergic receptor 29 . The top panel shows the individual channels (after corrections for bleed-through and wrong excitation), and the bottom panel shows the normalized ratio of the two channels.
Up to 20% changes in FRET ratio have been observed in several systems employing FlAsH with CFP. Obviously, these effects depend not only on the labels but more so on the biological system. Using FlAsH and ReAsH as labels, we have recently obtained a change in the FRET ratio of about 4% for a protein-protein interaction 45 . Successful labeling requires that the cysteine thiols of the tetracysteine tag be reduced. In oxidizing cellular compartments as the Golgi apparatus or the extracellular milieu, acute reduction with stronger reducing agents such as phosphines may be required (see also Figure 7 and TROUBLESHOOTING). 
